Related Experiment Video
Updated: Jan 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Parkinsonism in Gerstmann-Sträussler-Scheinker disease: A case report
Santiago Poveda1,2, Juan Sebastián Montealegre-Claros2, Lina María Lancheros3
1Instituto Roosevelt, Bogotá, D.C., Colombia.
Background:
Autosomal dominant prion diseases of the central nervous system, including Gerstmann-Sträussler-Scheinker disease (GSS), Creutzfeldt-Jakob disease, and fatal familial insomnia, are caused by mutations in the PRNP gene. These conditions exhibit highly variable clinical and pathological features, making diagnosis challenging, with poor survival outcomes. In Colombia, the incidence of prion diseases remains unknown. We report a case of GSS with parkinsonism, a rare presentation, emphasizing intrafamilial variability with the same pathogenic variant, underscoring the importance of reporting each case.
Case Presentation:
A 55-year-old woman from Colombia presented with symptoms of instability, rigidity, and bradykinesia. Over one year, her condition progressed to cognitive decline, dysphagia, and severe motor impairment. Differential diagnostic studies were conducted. A pathogenic P102L mutation in the PRNP gene was identified, confirming an autosomal dominant inheritance pattern. Symptomatic management and interdisciplinary rehabilitation were initiated. This mutation led to the diagnosis of at least 10 symptomatic family members and allowed for genetic counseling of asymptomatic relatives.
Conclusions:
This case of GSS with the P102L mutation demonstrates a late onset and rapid progression with atypical parkinsonism presentation, without ataxia, which is predominantly reported in previous cases. The familial segregation of this mutation highlights the importance of monitoring and following at-risk relatives. While the disease remains incurable, knowledge of genetic predisposition allows for better family planning and appropriate medical support, improving quality of life and emotional support.
More Related Videos
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation